Medical Journals

Targeted Disruption of the Pregnancy-associated Plasma Protein-a Gene is Associated with Diminished Smooth Muscle Cell Response to Insulin-like Growth Factor-i and Resistance to Neointimal Hyperplasia After Vascular Injury.

Authors:
  • Resch Zachary T
  • Simari Robert D
  • Conover Cheryl A

From: Department of Internal Medicine, Endocrine Research Unit, Mayo Clinic College of Medicine, 200 First Street Southwest, 5-194 Joseph, Rochester, Minnesota 55905, USA.

Endocrinology

  • Publish Date: Dec 2006
  • ISSN: 0013-7227
  • Volume: 147
  • Issue: 12
  • Pages: 5634-40
  • Medium: Print
  • Language: English
  • Citation (JAMA): Resch Zachary T, Simari Robert D, Conover Cheryl A, et al. Targeted Disruption of the Pregnancy-associated Plasma Protein-a Gene is Associated with Diminished Smooth Muscle Cell Response to Insulin-like Growth Factor-i and Resistance to Neointimal Hyperplasia After Vascular Injury.. Endocrinology Dec 2006;147:5634-40

Abstract

IGF-I is an important determinant of the vascular response to injury in large part through its ability to stimulate migration and proliferation of smooth muscle cells (SMCs). In this study, we used mice with targeted disruption of the pregnancy-associated plasma protein-A gene (PAPP-A-/-) and wild-type (WT) littermates to test the hypotheses that PAPP-A, a metalloproteinase that cleaves inhibitory IGF binding protein (IGFBP)-4, regulates vascular SMC responses to IGF-I in vitro and is critical for the development of vascular neointima after injury in vivo. Vascular SMCs from PAPP-A-/- mice lacked IGFBP-4 protease activity and failed to respond to treatment with IGF-I in the presence of IGFBP-4, whereas SMCs from WT mice with robust IGFBP-4 protease activity showed significant migratory and proliferative responses to IGF-I/IGFBP-4. For in vivo testing, PAPP-A-/- and WT mice underwent unilateral carotid ligation, a model of injury-induced neointimal hyperplasia. In WT mice, PAPP-A mRNA expression was markedly elevated 7 and 14 d after carotid ligation, associated with a progressive increase in neointimal hyperplasia and, in many cases, with complete occlusion of the vessel at 28 d. In contrast, PAPP-A-/- mice showed little evidence of progression resulting in a 75% reduction in neointimal area when compared with WT at 28 d. Cells staining for proliferating cell nuclear antigen were plentiful in the SMC-rich medial and neointimal areas of the injured WT vessel in stark contrast to the relatively few proliferating cells in the same areas of the PAPP-A-/- vessel. Expression of IGF-I and IGFBP-4 was similarly elevated in injured carotids from WT and PAPP-A-/- mice with no change in IGF-I receptor expression. IGFBP-5, an IGF-responsive gene, was increased 2-fold in WT but not in PAPP-A-/- carotids, suggesting reduced IGF activity in the absence of PAPP-A. Thus, PAPP-A-deficient mice are resistant to neointimal formation after injury, which may be explained in part by the ability of PAPP-A to enhance local IGF-I stimulation of vascular SMCs through proteolysis of IGFBP-4.

Mesh Headings (Keywords): Animals, Aorta, Carotid Artery Injuries, Cell Proliferation, Cells, Cultured, Gene Expression Regulation, Gene Targeting, Hyperplasia, Insulin-Like Growth Factor Binding Protein 4, Insulin-Like Growth Factor I, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Myocytes, Smooth Muscle, Pregnancy-Associated Plasma Protein-A, Tunica Intima


Check for Full Text / PubMed Unique Identifier (PMID): 16959843


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.